Hospital
RSSArticles
-
RSV, HMPV Outbreak Wreaks Havoc
This was the Apollo 13 of outbreaks—where just about everything that could go wrong did. And in that vein, those who tried valiantly to save all the lives they could embodied that doomed mission’s heroism. In this case, metaphorically speaking, everyone didn’t make it back.
-
Closing the Gap Between Patient, Worker Safety
Standard infection control precautions with all patients have been long recommended, but there is a surprising lack of definitive data about what role they actually play in protecting the patient and the healthcare worker.
-
IPs Can Provide Zika Education At Work, in the Community
In reporting another wave of tragic birth defects to babies born in the United States with Zika virus, public health officials urged healthcare providers to follow potential cases closely and reiterate prevention measures within their workplace and communities. Pregnant women are priority one.
-
Conduct a QA/QI Research Program Risk Assessment
Human research protection programs (HRPPs) are required to assess their quality, efficiency, and effectiveness if they’re seeking accreditation. HRPPs can do this through ongoing quality assurance/quality improvement (QA/QI) programs. But sometimes the quality improvement program also needs to be assessed for quality.
-
Creating an Optimal Research Training and Mentoring Program
A nine-year IRB chair veteran and a medical school’s associate dean identified gaps in their institution’s human research protection education. They noticed that online training was fine for general information, but came up short when investigators were struggling with specific protocol issues.
-
IRB Has Variety of Self-Assessment, Staff Assessment Tools
An Indiana research compliance program found that IRB staff and board assessments help keep the program on track and running well.
-
Researcher: Human Infection Trials for Zika Could Be Safely Performed
It sounds counterintuitive, but one of the main arguments for getting a Zika virus vaccine into human trials is that as susceptible people become immune through prior infection, it will be harder to test vaccine efficacy in a large population.
-
NIH Ethics Panel Vetoes Zika Human Infection Trials
While there are reports of various Zika vaccine trials proceeding, one the most promising methods to quickly and accurately measure vaccine efficacy has come to a full stop.
-
ANA Prepares for Return of Ebola – or Anything Else
As a result of the Ebola outbreak, the American Nurses Association has entered into training and resource collaborations with both the CDC and the Association for Professionals in Infection Control and Epidemiology.
-
OB Risk Reduction Focuses on Nurses, Detailed Timelines
While much of malpractice prevention efforts focus on physicians, nurses can be at risk of malpractice charges in this specialty.